5th Edition of International Heart Congress
June 24-26, 2027 | Hybrid Event
Ischemic Chest Pain
Ischemic chest pain, often referred to as angina, is a condition characterized by a temporary shortage of blood flow to the heart muscle. This occurs when the coronary arteries, which are responsible for delivering blood to the heart, experience narrowing or blockage. The restricted blood flow results in a tight, squeezing sensation or discomfort in the chest, commonly accompanied by shortness of breath, fatigue, and nausea. Ischemic chest pain is typically a symptom of underlying coronary artery disease, a condition where fatty deposits, known as plaque, build up within the arteries. While angina itself is usually not a heart attack, it serves as a crucial warning sign that the heart may not be receiving adequate oxygen. Timely medical attention and lifestyle modifications are essential in managing ischemic chest pain and reducing the risk of more severe cardiovascular events.
John R Doty
Intermountain Medical Center, United States
Agustin Joison
Cordoba Catholic University, Argentina
Thomas J Webster
Brown University, United States
Uwe Peter Tigor
Auxilius Pharma, United States
Sergey Suchkov
N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Bijoy Krishna Banik
National Institute of Pharmaceutical Education and Research (NIPER)-Guwahati, IndiaSubmit your abstract Today
Title : Healing a broken heart: One nano beat at a time
Thomas J Webster, Brown University, United States
Title : Revolutionizing heart health through Personalized & Precision Medicine (PPM): Towards personalized cardiovascular prevention, precision cardiac care & rehabilitation via optimizing Cardiac Hospital Networks
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Antibody-proteases as unique biomarkers, potential targets and translational tools of the next step generation to be used in personalized and precision cardiology practice
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Investigation of bergapten’s pharmacological activity against doxorubicin induced cardiotoxicity: supporting evidence from cellular and animal models
Bijoy Krishna Banik, National Institute of Pharmaceutical Education and Research (NIPER)-Guwahati, India
Title : Frequency of residual risk in cardiovascular secondary prevention in patients treated at the Reina Fabiola University Clinic
Agustin Joison, Cordoba Catholic University, Argentina
Title : Antidiabetic agents – From treating diabetes to providing positive cardiovascular outcome
Syed Raza, Awali Hospital, Bahrain